Synopsys, Inc. SNPS ← Back to all reports

Synopsys, Inc.

SNPS · Technology
B ★★★ Hold
Jul 15, 2026 · Score 84 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $433.82
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $415.00 ($400.00–$430.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $564.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+30.0%

Type A - Synopsys, Inc. (SNPS) 20260715 Stock Analysis

📅 Synopsys Key Upcoming Events

🏢 Step 1: Synopsys Company Overview & Business Model

Q1-A1. What is Synopsys?

Q1-A2. How Does Synopsys Make Money?

Q1-A3. Synopsys’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Synopsys’s Competitors?

Q1-A5. Synopsys Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Synopsys’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Synopsys Have a Durable Economic Moat?

Q2-A2. Is Synopsys’s Growth Sustainable?

Q2-A3. How Does Synopsys Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Synopsys Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Synopsys? (Margins & ROIC)

Q3-A3. What Drives Synopsys’s Returns? (ROIC Breakdown)

Q3-A4. Are Synopsys’s Earnings High Quality?

Q3-A5. Is Synopsys’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Synopsys Forensic Accounting & Dilution Review

Q4-A1. Does Synopsys Have Accounting Red Flags?

Q4-A2. Is Synopsys Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Synopsys’s Cash Flow?

Q4-A4. Is Synopsys Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Synopsys Management & Shareholder Alignment

Q5-A1. Can You Trust Synopsys’s Management? (Guidance Track Record)

Q5-A2. What Are Synopsys Insiders Doing?

Q5-A3. Is Synopsys’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Synopsys Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Synopsys Guidance

Q6-A2. What Is Synopsys’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Synopsys Catalysts & Price Triggers

Q7-A1. What Could Move Synopsys Stock? (Top 3 Catalysts)

Q7-A2. Synopsys’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Synopsys Fairly Valued? Valuation Analysis

Q8-A1. Synopsys’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Synopsys vs Peers: Valuation Comparison

Q8-A3. Is Synopsys Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Synopsys? (Reverse DCF)

Q8-A5. Valuation Cross-Check

Q8-A6. Synopsys’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Synopsys? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Synopsys?

Q9-A2. How Sensitive Is Synopsys to the Economy?

Q9-A3. Synopsys Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: Synopsys Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Synopsys? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Synopsys’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Synopsys’s Surging $10.8B Debt Load Its Biggest Weakness?

Q2: Can Synopsys’s 29x Forward P/E Be Justified by the Electrification Supercycle?

Q3: Will Elliott Management’s Board Presence Force Radical Margin Expansion?

Q4: How Severe is the Design IP Segment Transition for Long-Term Growth?

Q5: Can Synopsys Outcompete Cadence in Hardware-Assisted Verification (HAV)?

Q6: Will “Agentic AI” Break the Stagnant Flat-License Revenue Model?

Q7: Are China Export Controls a Fatal Threat to the EDA Market?

Q8: Does the Wave of Insider Selling Signal a Fundamental Peak?

Q9: What is the True Enterprise Value of the Ansys Multiphysics Fusion?

Q10: How Will the Software Integrity Divestiture Impact Financial Optics?

Synopsys, Inc. (SNPS)